Basilea Pharmaceutica AG (SWX: BSLN)

Basilea Pharmaceutica AG Balance Sheet

Financials in millions CHF. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	62.96	59.93	84.66	53.7	60.75	109.02
Short-Term Investments	-	-	-	95	101.02	20
Cash & Short-Term Investments	62.96	59.93	84.66	148.7	161.77	129.02
Cash Growth	-28.22%	-29.21%	-43.07%	-8.08%	25.38%	-42.15%
Accounts Receivable	28.08	27.89	33.15	24.95	8.71	6.24
Other Receivables	20.87	30.26	28.55	39.5	23.68	22.05
Receivables	48.95	58.15	61.7	64.45	32.39	28.3
Inventory	31.38	26.41	24.24	22.78	21.19	18.57
Restricted Cash	6.51	4.39	1.91	1.25	5.51	2.02
Other Current Assets	5.22	3.27	2.85	3.88	2.66	6.95
Total Current Assets	155.01	152.15	175.36	241.07	223.53	184.86
Property, Plant & Equipment	19.41	20.55	21.57	2.92	5.28	6.06
Long-Term Investments	-	-	-	-	-	30
Other Intangible Assets	0.47	0.55	0.58	0.63	0.67	0.37
Other Long-Term Assets	0.34	0.04	22.07	0.26	0.32	0.17
Total Assets	188.66	173.29	220.85	247.27	229.79	221.47
Accounts Payable	11.47	5.85	0.19	10.62	13.15	6.77
Accrued Expenses	11.5	13.1	18.9	27.9	21.3	25.5
Current Portion of Long-Term Debt	-	15.45	37.47	123.51	-	-
Current Portion of Leases	2.06	2.06	1.99	0.9	1.75	0.35
Current Income Taxes Payable	-	-	-	0.5	0.8	0.5
Current Unearned Revenue	1.23	1.23	1.23	1.23	2.56	32.87
Other Current Liabilities	11.52	9.9	15.07	9.76	10.6	9.5
Total Current Liabilities	37.78	47.59	74.85	174.41	50.16	75.49
Long-Term Debt	95.68	95.46	131.36	94.54	239.67	197.74
Long-Term Leases	14.7	15.64	16.32	0.01	0.9	0.55
Long-Term Unearned Revenue	8.84	9.46	10.69	11.93	13.16	16.47
Other Long-Term Liabilities	-	0	-0	-	0.16	0.17
Total Liabilities	171.88	183.29	241.56	305.87	331.84	314.43
Common Stock	13.17	13.1	13.09	12.99	11.92	11.88
Additional Paid-In Capital	1,045	1,042	1,037	1,030	982.44	927.34
Retained Earnings	-980.15	-1,001	-1,011	-1,023	-1,016	-1,002
Treasury Stock	-52.02	-54.01	-56.07	-56.56	-52.77	-5.96
Comprehensive Income & Other	-9	-10.21	-3.79	-21.62	-27.25	-24.56
Shareholders' Equity	16.79	-10	-20.72	-58.61	-102.05	-92.96
Total Liabilities & Equity	188.66	173.29	220.85	247.27	229.79	221.47
Total Debt	112.45	128.61	187.14	218.96	242.32	198.64
Net Cash (Debt)	-49.48	-68.67	-102.48	-70.26	-80.54	-69.62
Net Cash Per Share	-4.11	-5.66	-8.58	-6.01	-7.83	-6.47
Filing Date Shares Outstanding	12.12	12	11.95	11.84	10.87	10.77
Total Common Shares Outstanding	12.12	12	11.95	11.84	10.87	10.77
Working Capital	117.23	104.55	100.51	66.66	173.37	109.37
Book Value Per Share	1.38	-0.83	-1.73	-4.95	-9.39	-8.63
Tangible Book Value	16.31	-10.55	-21.29	-59.24	-102.72	-93.33
Tangible Book Value Per Share	1.35	-0.88	-1.78	-5.00	-9.45	-8.66
Land	-	-	-	-	0.2	1.5
Buildings	-	-	-	-	1.9	19
Machinery	12.43	12.86	12.98	16.62	24.63	23.66
Leasehold Improvements	1.8	1.8	1.8	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.